摘要 |
The invention relates to derivatives of 2-hydroxytetrahydrofuran corresponding to general formula (I) in which A represents the radical, in which R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>represent (in particular), independently, H, a halogen atom, OH, alkyl or alkoxy, R<SUP>3 </SUP>represents H, alkyl or -COR<SUP>10</SUP>, R<SUP>10 </SUP>representing H, alkyl or alkoxy, and W represents a bond, -CH<SUB>2</SUB>-CH<SUB>2</SUB>-, -CH-CH-, -O-, -S- or -NR<SUP>11</SUP>- in which R<SUP>11 </SUP>represents H or alkyl; X represents -CO-, -Y-CO-, -O-Y-CO- or -NR<SUP>12</SUP>-Y-CO-, Y represents an alkylene or haloalkylene alkyl, R<SUP>12 </SUP>represents H, alkyl or -COR<SUP>13</SUP>, R<SUP>13 </SUP>represents H, alkyl, haloalkyl or alkoxy, AA represents, each time that it occurs, a natural or non-natural amino acid; n represents 2 or 3; and finally R represents H, alkyl or -CO-R<SUP>19</SUP>, R<SUP>19 </SUP>representing alkyl. These compounds have a calpain inhibiting activity and/or an activity which traps the reactive oxygen species and can be used for preparing a medicament intended to treat the inflammatory and immunological diseases, cardio-vascular and cerebro-vascular diseases, disorders of the central or peripheral nervous system, cachexia, osteoporosis, muscular dystrophy, proliferative diseases, cataract, rejection reactions following organ transplants and autoimmune and viral diseases.
|